Munjaal Ruponi, the International Business Development Executive at K. Patel As global consumer interest in natural and preventive health solutions continues to rise, the integration of traditional wellness systems, such…

Munjaal Ruponi, the International Business Development Executive at K. Patel

As global consumer interest in natural and preventive health solutions continues to rise, the integration of traditional wellness systems, such as Ayurveda, into mainstream markets is gaining traction. In a strategic move to expand its international presence, India-based K. Patel Phyto Extractions has formed an exclusive partnership with Gonmisol, a well-established distributor of nutraceutical ingredients in Europe. In an interview with NUFFOODS Spectrum, Munjaal Ruponi, the International Business Development Executive at K. Patel, shares insights into the vision behind this partnership, how the company balances Ayurvedic authenticity with modern scientific principles, and what this collaboration signifies for the future of botanical wellness in global markets.

What makes this exclusive partnership with Gonmisol a strategic fit for K. Patel Phyto Extractions at this stage of your global growth? 

This partnership comes at a pivotal time for us. As global demand for natural health solutions continues to rise, especially in Europe, collaborating with Gonmisol allows us to bring our Ayurvedic botanical extracts closer to key markets. Their established presence, deep regional understanding and regulatory expertise complement our strengths in manufacturing. Together, we aim to make high-quality botanical ingredients more accessible, trusted and relevant to today’s wellness and nutraceutical brands. 

With Ayurveda gaining momentum in global wellness markets, how is K. Patel ensuring the authenticity, consistency, and scientific backing of its botanical extracts? 

For us, authenticity starts at the source. We work with long-standing cultivation partners across India, ensuring each herb is ethically sourced, traceable and true to its traditional identity. Every batch is processed under strict quality systems to deliver consistency in composition and performance. Our approach is grounded in preserving the integrity of Ayurveda while meeting the expectations of today’s global manufacturers for documentation, safety and quality control. 

Could you elaborate on the unique capabilities of your manufacturing and extraction facilities, and how they support international quality standards and scalability? 

Our facility in India is built to serve global markets with confidence. It is ISO 22000, GMP and FSSC 22000 certified, with a strong focus on process integrity, safety and traceability. We utilise advanced extraction technologies, including co-current systems and solvent processes, to ensure gentle, efficient, and scalable production. Our infrastructure is designed to support partners of all sizes, from emerging brands to established global companies, while aligning with the rigorous compliance expectations of regions such as the EU, US, and Asia-Pacific. 

What specific strengths does the K. Patel portfolio bring to the European and North American nutraceutical sectors, especially in women’s health and metabolic wellness? 

Many of the botanicals in our portfolio have been part of Ayurvedic tradition for centuries and continue to align with the wellness needs of today, particularly in areas such as women’s health, emotional wellbeing, digestion, and metabolic balance.

In terms of women’s health, our portfolio includes targeted botanicals such as:

• Shatavari (Asparagus racemosus) – a well-known adaptogen that supports estrogen balance, reproductive health, libido, and emotional resilience across all stages of a woman’s life.
• Fenugreek – traditionally used to support postpartum recovery and now widely studied for its role in hormonal balance, lactation, and metabolic conditions like PCOS.
• Triphala and Ginger – for gentle digestive support, gut regulation, and inflammatory balance.
• Curcumin – for its strong anti-inflammatory and antioxidant properties, increasingly relevant for women navigating perimenopause and oxidative stress.

Our extracts are designed to be versatile in formulation, compatible with capsules, powders, functional beverages, and more. By offering ingredients that are culturally familiar yet processed to modern quality standards (GMP, traceable, pesticide-free), we help brands develop trustworthy, effective products that bridge ancient wellness with contemporary consumer expectations.

How do you balance traditional Ayurvedic wisdom with modern R&D to create ingredients that meet both cultural and clinical expectations? 

We see ourselves as stewards of Ayurveda in a global context. Our team blends traditional knowledge with modern process understanding, ensuring that what we deliver is not only true to the original plant’s character but also compatible with international manufacturing and consumer requirements. This includes everything from standardisation to formulation support, while always keeping the essence of Ayurveda intact. It’s a balance of respect for the past and readiness for the future. 

What are your long-term ambitions for expanding the global footprint of Ayurvedic nutraceuticals, and how does this collaboration help you achieve them? 

Our long-term vision is to see Ayurvedic botanicals become a trusted and mainstream part of global wellness. We believe the principles of Ayurveda, which are balance, prevention and plant-based care, have universal appeal. This collaboration with Gonmisol allows us to move closer to that goal by creating local relevance, improving market responsiveness and building stronger ties with European formulators and brands. It’s a step toward making traditional Indian knowledge a valuable part of the global health conversation. 

Shraddha Warde

shraddha.warde@mmactiv.com